| Report ID |
3688 |
| Drug Identification Number |
02148625 |
| Brand name |
RIFATER |
| Common or Proper name |
RIFATER 120MG TABS |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
PYRAZINAMIDE
RIFAMPIN
ISONIAZID |
| Strength(s) |
300MG
120MG
50MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
60 |
| ATC code |
J04AM |
| ATC description |
DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
|
| Actual discontinuation date |
2016-07-29 |
| Remaining supply date |
2016-07-29 |
| Discontinuation status |
Discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
